Clinical Trial Update: A Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of MN-08 Tablets [Phase 1]

View source ↗

Summary

This document provides an update on a Phase 1 multiple-dose study evaluating safety, tolerability, and pharmacokinetics of MN-08 tablets for Pulmonary Arterial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• MN-08

Snippet

Sponsor: Guangzhou Magpie Pharmaceuticals Co., Ltd. | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: NOT_YET_RECRUITING